Key statistics
As of last trade, Dexcom Inc (DC4:FRA) traded at 70.80, 24.65% above the 52 week low of 56.80 set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 71.17 |
---|---|
High | 71.17 |
Low | 70.47 |
Bid | 70.73 |
Offer | 71.38 |
Previous close | 70.90 |
Average volume | 1.44k |
---|---|
Shares outstanding | 390.60m |
Free float | 389.35m |
P/E (TTM) | 45.93 |
Market cap | 29.39bn USD |
EPS (TTM) | 1.64 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 08:59 GMT.
More ▼
Press releases
- Dexcom and ŌURA Announce Strategic Partnership
- Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
- Dexcom Reports Third Quarter 2024 Financial Results
- Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time.
- Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
- Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
- Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
- Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium
- Dexcom Announces Upcoming Conference Presentation
- Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
More ▼